Parallel vs CoverMyMeds
Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris France YC W24 AI medical coding and admin agents for hospitals; $3.5M seed Apr 2025 led by Frst with Paul Meta/McKinsey and Thomas CTO adapting to fragmented hospital software competing with Nuance for healthcare admin automation.
About
Parallel is a Paris, France-based AI healthcare administration platform — backed by Y Combinator (W24) with $3.5 million in seed funding in April 2025 led by Frst with Y Combinator — providing hospitals and healthcare providers with vertical AI agents that automate time-consuming administrative tasks, starting with medical coding, using generative AI that streamlines hospital operations, improves billing accuracy, and reduces the administrative workload on medical staff — allowing clinicians to focus on patient care rather than documentation and coding compliance. Founded in 2024 by Paul Lafforgue (Meta/McKinsey background) and Thomas Sohet (CTO), with Yago as a co-founder, Parallel's 6-person Paris team designs AI agents that adapt to real-world hospital environments and fragmented software stacks.
Largest prior authorization network in the US connecting 75K+ pharmacies, 750K+ providers, and all payers. Columbus OH; acquired by McKesson; available free to providers and pharmacies;
About
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline the authorization process for prescription medications. Founded in 2008 in Columbus, Ohio, and acquired by McKesson Corporation in 2017, CoverMyMeds processes millions of prior authorization requests annually and has become foundational infrastructure for the US pharmacy and specialty medication market. The platform is available at no cost to providers and pharmacies and is funded through health plan and PBM partnerships.\n\nCoverMyMeds' network effect is central to its value: because the platform is used by the vast majority of pharmacies and a very large share of prescribing providers, payers can reach their entire provider and pharmacy network through a single connection. The platform supports real-time benefit checks that show the formulary status and prior authorization requirements for a drug at the point of prescribing, enabling providers to make more informed prescribing decisions before a patient reaches the pharmacy counter. Automated electronic prior authorization (ePA) workflows reduce approval times from days to hours for eligible drug-payer combinations.\n\nAs part of McKesson, CoverMyMeds has expanded its capabilities to include specialty medication access solutions, patient assistance program enrollment, and medication adherence tools. The company's RxCrossroads subsidiary provides hub services for specialty pharmaceutical manufacturers, creating a comprehensive access ecosystem that spans from initial authorization through patient support and adherence management.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.